These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 31579860)

  • 21. Effects of the Mu opioid receptor polymorphism (OPRM1 A118G) on pain regulation, placebo effects and associated personality trait measures.
    Peciña M; Love T; Stohler CS; Goldman D; Zubieta JK
    Neuropsychopharmacology; 2015 Mar; 40(4):957-65. PubMed ID: 25308352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dynamic interactions between plasma IL-1 family cytokines and central endogenous opioid neurotransmitter function in humans.
    Prossin AR; Zalcman SS; Heitzeg MM; Koch AE; Campbell PL; Phan KL; Stohler CS; Zubieta JK
    Neuropsychopharmacology; 2015 Feb; 40(3):554-65. PubMed ID: 25139063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Magnetic resonance imaging (MRI) for the assessment of myocardial viability: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(15):1-45. PubMed ID: 23074392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simultaneous fMRI-PET of the opioidergic pain system in human brain.
    Wey HY; Catana C; Hooker JM; Dougherty DD; Knudsen GM; Wang DJ; Chonde DB; Rosen BR; Gollub RL; Kong J
    Neuroimage; 2014 Nov; 102 Pt 2(0 2):275-82. PubMed ID: 25107855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular and functional PET-fMRI measures of placebo analgesia in episodic migraine: Preliminary findings.
    Linnman C; Catana C; Petkov MP; Chonde DB; Becerra L; Hooker J; Borsook D
    Neuroimage Clin; 2018; 17():680-690. PubMed ID: 29255671
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Positron emission tomography measures of endogenous opioid neurotransmission and impulsiveness traits in humans.
    Love TM; Stohler CS; Zubieta JK
    Arch Gen Psychiatry; 2009 Oct; 66(10):1124-34. PubMed ID: 19805703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroimaging of opioid exposure: a review of preclinical animal models to inform addiction research.
    Kamens HM; Cramer S; Hanley RN; Chase S; Wickenheisser A; Horton WJ; Zhang N
    Psychopharmacology (Berl); 2023 Dec; 240(12):2459-2482. PubMed ID: 37857897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Imaging Kappa Opioid Receptors in the Living Brain with Positron Emission Tomography.
    Placzek MS
    Handb Exp Pharmacol; 2022; 271():547-577. PubMed ID: 34363128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relevance of functional neuroimaging studies for understanding migraine mechanisms.
    Tedeschi G; Russo A; Tessitore A
    Expert Rev Neurother; 2013 Mar; 13(3):275-85. PubMed ID: 23448217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immediate effects of tDCS on the μ-opioid system of a chronic pain patient.
    DosSantos MF; Love TM; Martikainen IK; Nascimento TD; Fregni F; Cummiford C; Deboer MD; Zubieta JK; Dasilva AF
    Front Psychiatry; 2012; 3():93. PubMed ID: 23130002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aerobic exercise modulates anticipatory reward processing via the μ-opioid receptor system.
    Saanijoki T; Nummenmaa L; Tuulari JJ; Tuominen L; Arponen E; Kalliokoski KK; Hirvonen J
    Hum Brain Mapp; 2018 Oct; 39(10):3972-3983. PubMed ID: 29885086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(16):1-80. PubMed ID: 23074393
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Objective methods for the assessment of the spinal and supraspinal effects of opioids.
    Fischer IW; Hansen TM; Lelic D; Brokjaer A; Frøkjær J; Christrup LL; Olesen AE
    Scand J Pain; 2017 Jan; 14():15-24. PubMed ID: 28850426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimizing Placebo and Minimizing Nocebo to Reduce Pain, Catastrophizing, and Opioid Use: A Review of the Science and an Evidence-Informed Clinical Toolkit.
    Darnall BD; Colloca L
    Int Rev Neurobiol; 2018; 139():129-157. PubMed ID: 30146045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Revealing the Neural Mechanism Underlying the Effects of Acupuncture on Migraine: A Systematic Review.
    Liu L; Tian T; Li X; Wang Y; Xu T; Ni X; Li X; He Z; Gao S; Sun M; Liang F; Zhao L
    Front Neurosci; 2021; 15():674852. PubMed ID: 34093119
    [No Abstract]   [Full Text] [Related]  

  • 36. Imaging of opioid receptors in the central nervous system.
    Henriksen G; Willoch F
    Brain; 2008 May; 131(Pt 5):1171-96. PubMed ID: 18048446
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Building up analgesia in humans via the endogenous μ-opioid system by combining placebo and active tDCS: a preliminary report.
    DosSantos MF; Martikainen IK; Nascimento TD; Love TM; DeBoer MD; Schambra HM; Bikson M; Zubieta JK; DaSilva AF
    PLoS One; 2014; 9(7):e102350. PubMed ID: 25029273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular mechanisms of placebo responses in humans.
    Peciña M; Zubieta JK
    Mol Psychiatry; 2015 Apr; 20(4):416-23. PubMed ID: 25510510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroimaging of the human visceral pain system-A methodological review.
    Frøkjær JB; Olesen SS; Graversen C; Andresen T; Lelic D; Drewes AM
    Scand J Pain; 2018 Jul; 2(3):95-104. PubMed ID: 29913746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroimaging of pain mechanisms.
    Tracey I
    Curr Opin Support Palliat Care; 2007 Aug; 1(2):109-16. PubMed ID: 18685351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.